Selected article for: "influenza virus and pathogen surveillance"

Author: Chan, Joseph M.; Rabadan, Raul
Title: Quantifying Pathogen Surveillance Using Temporal Genomic Data
  • Document date: 2013_1_29
  • ID: u2t1x89m_29
    Snippet: In this paper, we offer a quantitative method of measuring the quality of surveillance of a particular pathogen that reflects its evolutionary rate and genetic diversity. The q2 coefficient repre- sents an easily interpretable quantitative measure of genomic surveillance that does not rely on a full phylogenetic reconstruction. A number between 0 and 1, the q2 coefficient reflects the fraction of isolates with a closest isolate in the past within.....
    Document: In this paper, we offer a quantitative method of measuring the quality of surveillance of a particular pathogen that reflects its evolutionary rate and genetic diversity. The q2 coefficient repre- sents an easily interpretable quantitative measure of genomic surveillance that does not rely on a full phylogenetic reconstruction. A number between 0 and 1, the q2 coefficient reflects the fraction of isolates with a closest isolate in the past within 2 years of evolution. However, in its simplicity, the q2 coefficient does not capture the complexity of evolutionary processes such as variable evolutionary rates, recombination, reassortment, and population genetic effects. We decided on the q2 coefficient instead of other equally valid metrics (Q1, q5, or q100) because 2 years represents the median influenza A virus vaccine update time. However, different metrics may be applicable, depending on the specific aim of the surveillance program.

    Search related documents:
    Co phrase search for related documents
    • different metric and evolutionary rate: 1
    • evolutionary process and genetic diversity: 1, 2, 3, 4, 5, 6, 7, 8
    • evolutionary process and genomic surveillance: 1
    • evolutionary process and phylogenetic reconstruction: 1
    • evolutionary process and virus vaccine: 1
    • evolutionary rate and genetic diversity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
    • evolutionary rate and genomic surveillance: 1, 2, 3, 4, 5, 6
    • evolutionary rate and median influenza: 1
    • evolutionary rate and phylogenetic reconstruction: 1, 2, 3
    • evolutionary rate and quantitative measure: 1
    • evolutionary rate and quantitative method: 1
    • evolutionary rate and variable evolutionary rate: 1, 2
    • evolutionary rate and virus vaccine: 1
    • genetic diversity and genomic surveillance: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22
    • genetic diversity and median influenza: 1
    • genetic diversity and particular pathogen: 1
    • genetic diversity and phylogenetic reconstruction: 1, 2, 3, 4, 5
    • genetic diversity and quantitative method: 1
    • genetic diversity and specific aim: 1